Affiliation:
1. From the Department of Physiology and Pharmacology (J.C., N.W., A.D.K.) and Department of Neurology (J.C., T.A.T., A.D.K., N.M.B.), Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Abstract
Background and Purpose
—There is a growing interest in the use of genetic markers in the differential diagnosis of dementia. In the current study we examined the usefulness of genetic risk factors for vascular disease as markers for vascular dementia (VD).
Methods
—The groups included 41 patients with VD, 49 patients with dementia of the Alzheimer’s type, and 40 age-matched control subjects without dementia. These patients were genotyped for vascular disease–associated polymorphisms in the genes coding for methylenetetrahydrofolate reductase (MTHFR), angiotensin-converting enzyme (ACE), factor V Leiden (FVL), and a common genetic risk factor for AD, apolipoprotein E ε4 (APOE ε4).
Results
—There was no significant association between ACE, MTHFR, and FVL genotypes with VD whether compared with subjects with AD or with control subjects. There was a higher frequency of APOE ε4 alleles in patients with AD (30%,
P
=0.016) and VD (26%,
P
=0.07) compared with control subjects (15%).
Conclusions
—VD is not associated with the genetic risk factors for vascular disease examined in this study, indicating that the pathogenesis of VD may differ from other vascular diseases.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology
Cited by
110 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献